Table 2 Definitions of epitopic sites (ES) seen by Abs and Nbs.

From: SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain

ES

RBD residue (range)

Amino acid sequence

Structural feature

ASA (Ă…2)

Abs (H chain) (%)

Nbs (%)

1

339–341

GEV

α-helix

155

0.78

0.16

2

343–349

NATRFAS

loop

455

4.07

2.83

3

351–357

YAWNRKR

310 ->β-strand

410

2.60

3.76

4

368–374

LYNSASF

α-helix->loop

469

3.17

7.03

5

375–380

STFKCY

β-strand

287

2.90

6.97

6

381–386

GVSPTK

Loop->310

381

2.49

5.50

7

403–409

RGDEVRQ

310

321

2.76

4.68

8

411–417

APGQTGK

loop

342

4.91

2.78

9

420–428

DYNYKLPDD

α-helix->loop

371

3.24

1.69

10

437–443

NSNNLDS

β-strand->α-helix

378

3.59

1.47

11

444–449

KVGGNY

loop/strand

457

7.10

8.39

12

450–454

NYLYR

β-strand

194

4.57

5.72

13

455–460

LFRKSN

loop

448

9.98

4.25

14

462–467

KPFERD

loop

470

1.28

1.31

15

468–472

ISTEI

loop

384

2.44

4.47

16

473–479

YQAGSTP

β-strand->loop

466

9.34

0.71

17

481–484

NGVE

loop

404

4.36

5.28

18

485–487

GFN

loop

275

7.06

3.65

19

488–491

CYFP

β-strand->loop

181

5.98

5.88

20

492–496

LQSYG

β-strand

126

7.15

9.69

21

497–502

FQPTNG

loop

307

3.38

2.94

22

503–509

VGYQPYR

310->β-strand

253

2.42

4.14

23

516–520

ELLHA

loop

548

0.44

1.20

  1. RBD residue range for each ES is indicated, along with the amino acid sequence, secondary structural features (as determined by DSSP78), accessible surface area (ASA) (see Methods) of the contacting residues, and percentage of Ab H chains and Nbs.